1 year return (CAGR)
-99.32%
Impel Neuropharma Inc Exchange (NASDAQ, USD)
IMPL
-
-0.00 (-21.50%)
NASDAQ
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
375.23K
Price/Sales
0.02
Ent value
127.11M
Price/Book
-
Div yield
-
Growth years
-
Div growth
-
FCF payout
-0.10%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.02 |
| Daily high | 0.02 |
| Daily low | 0.01 |
| Daily Volume | 13K |
| 1y analyst estimate | 40.00 |
| Beta | 1.17 |
| EPS (TTM) | -4.05 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IMPL | S&P500 | |
| Current price drop from All-time high | -99.94% | -0.50% |
| Highest price drop | -99.96% | -56.47% |
| Date of highest drop | 12 Feb 2024 | 9 Mar 2009 |
| Avg drop from high | -74.53% | -10.68% |
| Avg time to new high | 102 days | 12 days |
| Max time to new high | 636 days | 1805 days |
News
No items found